High serum periostin has been identified as a factor for poor prognosis in lung cancer [14, 15, 20, 21], and periostin overexpression in NSCLC tissue, identified by IHC, is also correlated with a poor prognosis [16–19]. The gene discussed is POSTN; the disease is lung carcinoma.